Device Trial Radar · NCT07949097
RASSURE - Virtual Reality to Soothe, Secure, Simulate Uses, and Successfully Complete the Examination
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Dec 1, 2026
Primary completion
Mar 30, 2028
Study completion Mar 30, 2028
Sponsor
- Lead sponsor
- Pôle Saint HélierAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 19, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Health services research
- FDA-regulated device
- No
- Who can join
- All sexes, from 9 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The RASSURE study aims to evaluate the effect of a preparation for care programme combining a traditional habituation method with a digital immersive virtual reality tool ('PREPASOINS\_VR'), compared with traditional habituation alone. In particular, the study aims to measure the impact of the use of IVR on the anxiety experienced during the actual treatment, as well as on various indicators relating to the delivery of the treatment, its progress and the experience of the patients.
Conditions
- Psychological Disability
- Mental Disability
Interventions
Traditional care habituation programmeBehavioral
A traditional care habituation programme designed to familiarise participants with upcoming medical and care procedures. The programme uses conventional preparation materials and information to help participants understand and anticipate the different stages of the procedures. It aims to reduce anxiety associated with medical and care procedures. This intervention is provided to participants in both the control and experimental groups. In the experimental group, it is supplemented by an immersive virtual reality familiarisation programme (PREPASOINS\_VR).
Embrace Plus wristbandDevice
The Embrace Plus wristband is worn by participants in both study groups to monitor anxiety levels during the study. It is used as a monitoring device and does not deliver any therapeutic intervention.
PREPASOINS_VR virtual reality headsetDevice
An immersive virtual reality headset used with the PREPASOINS\_VR solution. The device enables participants to view immersive 360-degree videos presenting different medical and care scenarios as part of the care familiarisation programme. It is used exclusively in the experimental group.
Dummy wristbandDevice
A non-electronic dummy wristband used during the treatment habituation sessions to familiarise participants with wearing a wristband before the actual treatment procedure. The dummy wristband is used for habituation purposes only and does not record or monitor physiological parameters.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Skin Conductance (SC) During the Actual Treatment Procedure (µS)Time frame: At Visit 1, during the actual treatment procedure (2-3 months after enrolment).
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Fondation Saint-Hélier
Rennes, France
MAS le Placis Vert - DAPAH - CHGR
Thorigné-Fouillard, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.